Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 10 - 27 crawled time : 12:15 save search
Critical Connectivity at the Rebelle Rally – Q & A With Iridium Partner Icom
Published: 2021-10-27 (Crawled : 12:15) - iridium.com
IRDM | News | $29.29 1.91% 1.88% 1.9M
|
Communications
|
| O: 0.02%
H: 0.5%
C: -2.75%
INOVIO to Report Third Quarter 2021 Financial Results on November 9, 2021
Published: 2021-10-27 (Crawled : 12:15) - inovio.com
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: -1.71%
H: 1.15%
C: -1.59%
financial results results
Werewolf Therapeutics to Present Data on its INDUKINE™ Product Candidates at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
HOWL | $6.405 -0.54% -0.55% 82K
|
Professional, Scientific, and T...
|
| O: -1.04%
H: 3.94%
C: 1.64%
immunotherapy therapy cancer
Aptevo Therapeutics Presents Promising Clinical Data on Its Lead Leukemia Drug Candidate APVO436 at The Second Virtual Conference on Controversies in Leukemias, Euroleuk2021
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
APVO | $0.6827 -7.27% -7.84% 570K
|
Health Technology
|
| O: -0.96%
H: 2.83%
C: 0.69%
drug leukemia conference apvo436
Why the future of the public sector is increasingly automated
Published: 2021-10-27 (Crawled : 12:15) - capgemini.com
XYF | News | $3.815 -1.74% 0.39% 5.4K
|
Finance
|
| O: 0.22%
H: 2.41%
C: -1.32%
publication
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
ADAG | $2.65 -2.63% 740
|
Manufacturing
| Email alert
Add to watchlist
lung cancer collaboration cancer trial nivolumab
InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
IFRX | $1.355 -0.37% -0.37% 71K
|
Health Technology
|
| O: 1.75%
H: 3.09%
C: -1.72%
positive
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy– Pasithea Clinics
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
KTTA | $7.09 -1.19% 910
|
|
| O: 2.95%
H: 43.37%
C: 6.09%
treatment therapy ketamine depression
IN8bio’s Announces Peer-Reviewed Publication of Preclinical Results Using Proprietary MGMT-modified Gamma-Delta T Cells (INB-200) with Temozolomide in Mouse Models of Glioblastoma Multiforme
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
INAB | $1.03 -0.96% -0.97% 150K
|
|
| O: 0.37%
H: 3.05%
C: -7.81%
results preclinical t-cell pre-clinical glioblastoma
Ballantyne Strong to Announce 2021 Third-Quarter Financial Results and Host Conference Call on November 10, 2021
Published: 2021-10-27 (Crawled : 12:15) - ballantynestrong.com
FGF | News | $1.33 0.76% 0.75% 50K
|
Finance and Insurance
|
| O: 2.83%
H: 0.5%
C: -1.25%
financial results results conference
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.